CIK 0001159036
- Large accelerated filer
HALOZYME THERAPEUTICS, INC.
Sign in to watch- Ticker
- HALO
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 880488686
- Phone
- +1 858-794-8889
- Business address
- 12390 EL CAMINO REAL, SAN DIEGO, CA, 92130
- Former names
- HALOZYME THERAPEUTICS INC, GLOBAL YACHT SERVICES INC
- 4 Open-market sale PRESIDENT AND CEO sold 30,000 shares at an average $51.01 ($1,530,150)
- 4 Grant or award Director acquired 1,188 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale PRESIDENT AND CEO sold 30,000 shares at an average $51.30 ($1,539,149)
- 4 Open-market sale SVP, CHIEF TECHNICAL OFFICER sold 10,000 shares at an average $50.46 ($504,590)
- 4 Shares withheld for taxes SVP, GENERAL COUNSEL gave up 2,804 shares (to pay taxes)
- 4 Open-market sale PRESIDENT AND CEO sold 30,000 shares at an average $58.11 ($1,743,302)
- 4 Open-market sale SVP, CHIEF TECHNICAL OFFICER sold 10,000 shares at an average $58.67 ($586,675)
- 4 Open-market sale Director sold 30,000 shares at an average $56.89 ($1,706,550)
- 4 Gift Director gave 9,250 shares (gift)
- 4 Gift Director gave 5,998 shares (gift)
- 4 Open-market sale PRESIDENT AND CEO sold 30,000 shares at an average $53.39 ($1,601,626)
- 4 Open-market sale SVP, CHIEF FINANCIAL OFFICER sold 5,000 shares at an average $53.81 ($269,053)
- 4 Open-market sale SVP, CHIEF TECHNICAL OFFICER sold 10,000 shares at an average $54.13 ($541,263)
- 4 Grant or award Director acquired 6,206 shares (grant or award)
- 4 Grant or award Director acquired 6,206 shares (grant or award)
- 4 Grant or award Director acquired 6,206 shares (grant or award)
- 4 Grant or award Director acquired 6,206 shares (grant or award)
- 4 Grant or award Director acquired 6,206 shares (grant or award)
- 4 Grant or award Director acquired 6,206 shares (grant or award)
Page 10 of 39 · 775 filings